Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Maximizing Bioavailability and Commercial Success with Softgels | Contract Pharma

What are you searching for?

Sign in
Sponsored Content

Maximizing Bioavailability and Commercial Success with Softgels

Released By Douglas CDMO

This session will explore the critical role of bioavailability in a drug’s success and how softgel technology can be a strategic solution for commercial longevity. Dr. Peter Surman, Dr. Brett Wagner, and Chris Cuthbertson will look at how a molecule’s market potential is often limited not by its efficacy but by its poor delivery and absorption. They will explain the scientific challenges of bioavailability, such as poor solubility and stability, and how these issues can lead to increased R&D costs, clinical trial failures, and lost market share.

Using case studies they will demonstrate how strategic formulation can overcome significant challenges, such as a drug’s food effect or very low bioavailability. Finally, they will share how early-stage molecule characterization and a partnership with a company like Douglas can be crucial for navigating the complex pathway from candidate selection to market, ultimately helping clients accelerate their drug’s journey to patients and achieve market leadership.

Speakers:

  • Dr. Peter Surman – Chief Scientific Officer, Douglas CDMO
  • Dr. Brett Wagner – R&D Evaluation Manager, Douglas CDMO
  • Chris Cuthbertson – Program Manager for Pharmaceutical Development, Douglas CDMO

Request more information from Douglas CDMO

Request more information from Douglas CDMO

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics